RT Journal Article
T1 Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs
A1 López Abente, Jacobo
A1 Benito Villalvilla, Cristina
A1 Jaumont, Xavier
A1 Pfister, Pascal
A1 Tassinari, Paolo
A1 Palomares Gracia, Óscar
AB IgE-FcεR1 cross-linking on human pDCs impairs their capacity to generate regulatory T-cells and in vitro omalizumab restores this ability. These findings may pave the way for novel biomarkers to assess omalizumab clinical efficacy and responder patients.
PB European Respiratory Society
SN 0903-1936
YR 2021
FD 2021
LK https://hdl.handle.net/20.500.14352/95318
UL https://hdl.handle.net/20.500.14352/95318
LA eng
NO López-Abente J, Benito-Villalvilla C, Jaumont X, Pfister P, Tassinari P, Palomares O. Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+Tregs. Eur Respir J. 2021 Jan 14;57(1):2000751. doi: 10.1183/13993003.00751-2020
NO Ministerio de Ciencia, Innovación y Universidades (España)
NO Novartis
NO Ministerio de Economía y Competitividad (España)
DS Docta Complutense
RD 18 dic 2025